Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and Retinopathy in South Wales

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorHywel Dda Health Board

About this trial

Diabetes mellitus is a disorder of sugar and fat metabolism which results in damage to the small blood vessels in various organs, this includes the retina - the part of the eye that processes light into a nerve impulse. This leads to damage and blindness via various different mechanisms that are not fully understood.

In this study the objective is to recruit people with diabetes and various stages of diabetic eye disease and measure a large number of different chemicals within the blood that might be associated with damage and dysfunction within the retina. Additionally, it will examine the different bacteria within the gut that might affect disease in the eye via chemicals circulating in the blood. This will require participants to have blood samples taken and to provide urine samples. The blood will be analysed with specialised instruments to identify specific molecules circulating within the blood. Participants will also need to allow researchers to look at their medical records, previous photographs and specialist scans of the back of the eye to grade their diabetic retinopathy. This will allow us to identify potential ways in which these could be targeted for future benefit for people with diabetes to hopefully prevent deterioration of their vision.

Eligibility criteria

Qualifiers

Diagnosis of type 2 diabetes mellitus

Male or female aged 18 - 80 inclusive

Disqualifiers

Participant unable or unwilling to consent to inclusion in the study

Prior treatment with intravitreal therapies for DMO

Potential participant with a known infective disease that may put the study team at risk (eg. TB, HIV, hepatitis)

Age 17 yo or less or 81 yo or older

Trial design

Treatments tested in this trial

  • Blood draw for the laboratory assessment
  • Urine sample

Treatment groups

120 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.

Sponsors and collaborators

Hywel Dda Health Board

Lead sponsor

University of Aberdeen

Collaborator